OKYO Pharma annual capital expenditures (capex)
2021
2022
2023
2025
2026
OKYO Pharma Capital Expenditures (CapEx) Growth & History (OKYO)
OKYO Pharma's capital expenditures (capex) was $6,080 for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $6,080 | $4,872 | +403.31% |
| 2025 | 2025-03-31 | $1,208 | — | — |
| 2023 | 2023-03-31 | $5,916 | $4,247 | +254.46% |
| 2022 | 2022-03-31 | $1,669 | −$5,274 | −75.96% |
| 2021 | 2021-03-31 | $6,943 | — | — |
OKYO Pharma capital expenditures (capex) trends
Over the last five fiscal years, OKYO Pharma's capital expenditures (capex) decreased from $6,943 to $6,080, a change of −$863.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗